Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-04-08 16:43:07 ET · period of report 2026-04-06 · accession 0001532218-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-08 16:43 | 2026-04-06 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $10.36 | +7,278 | 7,278 | New | +$75.4K |
| DT | 2026-04-08 16:43 | 2026-04-06 | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $50.01 | -7,278 | 0 | -100% | -$364.0K |
| DTI | 2026-04-08 16:43 | 2026-04-07 | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | — | +9,991 | 81.0K | +14% | — |
| DTI | 2026-04-08 16:43 | 2026-04-07 | KNSA | Patel Sanj K | COB, CEO, Dir | F - Tax | $48.94 | -4,831 | 76.2K | -6% | -$236.4K |
| DMT | 2026-04-08 16:43 | 2026-04-06+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -17.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-04-06 | M | A | 7,278 | $10.36 | 7,278 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. |
| 2 | Common | Class A Ordinary Share | 2026-04-06 | S | D | 7,278 | $50.01 | 0 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.005 and $50.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2026-04-07 | M | A | 9,991 | — | 81,005 | I Held by The Patel Family Irrevocable Trust of 2025 | — | — | (F3) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 4 | Common | Class A Ordinary Share | 2026-04-07 | F | D | 4,831 | $48.94 | 76,174 | I Held by The Patel Family Irrevocable Trust of 2025 | — | — | |
| 5 | Derivative | Share Option | 2026-04-06 | M | D | 7,278 | $0.00 | 431,904 | D | $10.36 · — to 2028-02-29 | 7,278 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 6 | Derivative | Restricted Share Unit | 2026-04-07 | M | D | 9,991 | $0.00 | 0 | D | — · — to — | 9,991 Class A Ordinary Share | (F3) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSs vesting on the yearly anniversary of the grant date, April 7, 2022. (F5) The RSUs vest over a four-year period, with 25% of the RSs vesting on the yearly anniversary of the grant date, April 7, 2022. |